Medical Science News

RSS

Study suggests seropositive individuals produce anti-SARS-CoV-2 antibodies with improved potency and breadth

Researchers isolated single cells among individuals with and without prior infection with the SARS-CoV-2 vaccinated with BNT162b2 mRNA vaccine and compared the nature of the neutralizing antibody response against the original Wuhan virus and the subsequent variants.

25 Oct 2021

Nanoparticle-mediated, slow-release delivery of TT-10 enhances heart attack recovery in mouse model

A heart attack kills heart muscle cells, leading to a scar that weakens the heart, often leading to eventual heart failure. The lack of muscle repair is due to the very limited ability of mammalian heart muscle cells to proliferate, except for a brief period around birth.

25 Oct 2021

Rutgers study links genetic disorders to walking patterns

Rutgers researchers have linked the genetic disorders Fragile X and SHANK3 deletion syndrome – both linked to autism and health problems – to walking patterns by examining the microscopic movements of those wearing motion-sensored sneakers.

25 Oct 2021

Molecular mechanism that controls the transition from acute to chronic pain revealed

A new study led by University of California, Irvine researchers is the first to reveal the specific molecular mechanism that controls the transition from acute to chronic pain, and identifies this mechanism as a critical target for disease-modifying medicines.

25 Oct 2021

Innovative in vitro platform to evaluate the cardiotoxicity of chemicals

People are continuously exposed to a huge amount and variety of potentially toxic chemicals present in the surrounding environment, such as pesticides or drugs traces in water, soil, air and living organisms. The combined action of pollutants can increase the risk of toxic effects.

25 Oct 2021

Targeting SARS-CoV-2 with Chaga mushroom – a natural antiviral compound

A new study examines the potential binding interaction of the beneficial components of Chaga mushroom with that of the SARS-CoV-2 RBD.

24 Oct 2021

Immune evasion by SARS-CoV-2 facilitated by a mutational hotspot in the NTD

Researchers discuss mutations in the NTD of the spike protein, which contains an antigenic “supersite” and is the target for nAbs.

24 Oct 2021

Mapping the molecular gene signatures of respiratory viruses, including SARS-CoV-2

Researchers compare a large cohort of transcriptomic dataset maps of gene regulation by SARS-CoV-2 infection.

24 Oct 2021

Vaccination data from Puerto Rico strongly supports COVID19 booster shots

In a recent study, researchers from the U.S. examined the vaccine effectiveness against SARS-CoV-2 infections in Puerto Rico.

24 Oct 2021

Study findings may lead to new treatments to fight deadly C. difficile infections

A University of California, Irvine-led study suggests that the glucosyltransferase domain (GTD) is an ideal molecular target for therapeutic interventions for Clostridioides difficile infection (CDI). These findings may lead to new treatments to fight this deadly disease.

22 Oct 2021

Specific amino acid supplementation could prevent the development of dementia

Dementia- a condition involving the extreme loss of cognitive function- is caused by a variety of disorders, including Alzheimer's disease.

22 Oct 2021

Gene therapy strategy against Angelman syndrome shows early promise

Scientists at the UNC School of Medicine have reported in the journal JCI Insight encouraging early tests of a gene therapy strategy against Angelman syndrome, a neurodevelopmental disorder that features poor muscle control and balance, hard-to-treat epilepsy, and intellectual disabilities.

22 Oct 2021

Medical Science News

Study suggests seropositive individuals produce anti-SARS-CoV-2 antibodies with improved potency and breadth

Nanoparticle-mediated, slow-release delivery of TT-10 enhances heart attack recovery in mouse model

Rutgers study links genetic disorders to walking patterns

Molecular mechanism that controls the transition from acute to chronic pain revealed

Innovative in vitro platform to evaluate the cardiotoxicity of chemicals

Targeting SARS-CoV-2 with Chaga mushroom – a natural antiviral compound

Immune evasion by SARS-CoV-2 facilitated by a mutational hotspot in the NTD

Mapping the molecular gene signatures of respiratory viruses, including SARS-CoV-2

Vaccination data from Puerto Rico strongly supports COVID19 booster shots

Study findings may lead to new treatments to fight deadly C. difficile infections

Specific amino acid supplementation could prevent the development of dementia

Gene therapy strategy against Angelman syndrome shows early promise

Study reveals key role of fat cells in cognitive decline and neurodegeneration

Researchers identify mechanism behind insufficient treatment efficacy of psoriasis drugs

Chemical substance may specifically inhibit both SARS-CoV-2 proteases and human protease

Mu and C.1.2 variant spike proteins partially resistant to neutralization by vaccine-elicited antibodies

SARS-CoV-2 anti-nucleocapsid antibodies reduce risk of reinfection for at least eight months

Study shows immune profile heterogeneity amongst healthy adults

Using saliva to predict COVID-19 severity in children

Health and climate change in Australia

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Latest News